Spacelintech
Space LiinTech is a space-based biopharmaceutical company that develops and operates research platforms for protein crystallization and biomanufacturing in microgravity environments. The company utilizes International Space Station modules, satellite-based systems, and ground-based drop towers to support drug discovery and life science research.
verified 17 July 2026
↗ BUSINESS↗ Space LiinTech↗ ABOUT US-overviewFact sheet
- Founded 2021↗ The next drug lab is in orbit - The Korea Herald↗ Space LiinTech↗ StartUp_스페이스린텍↗ Space LiinTech
- HQ in Daejeon, South Korea↗ The next drug lab is in orbit - The Korea Herald↗ Space LiinTech↗ StartUp_스페이스린텍↗ Space LiinTech
- Total funding $2.9M↗ The next drug lab is in orbit - The Korea Herald↗ Space LiinTech↗ StartUp_스페이스린텍↗ Space LiinTech
- Key products: BEE-PC1 (protein crystallization module), BEE-1000 (cube satellite)↗ The next drug lab is in orbit - The Korea Herald↗ Space LiinTech↗ StartUp_스페이스린텍↗ Space LiinTech
- Notable partners: Korea Institute of Science and Technology (KIST), Harvard Medical School↗ The next drug lab is in orbit - The Korea Herald↗ Space LiinTech↗ StartUp_스페이스린텍↗ Space LiinTech
Recent developments
A July 2026 article confirms Spacelintech has secured a berth on a commercial space station for orbital pharmaceutical manufacturing, reinforcing its positioning as a pioneering Korean space biotech company in this sector.
Read more ↗biz.heraldcorp.com14 Jul